Talk:Choline bitartrate

Revision as of 23:32, 23 March 2018 by >David Hedlund (DL-choline bitartrate)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

DL-choline bitartrate

“DL-Choline Bitartrate should not be used in pharma or food applications although the price is normally more attractive. Studies have that shown the DL-form has nefrotoxic effects (1). In Europe, according to the CODEX and European Union, only L-Choline Bitartrate is allowed because it is mentioned in DAB and in the USP monograph. The DL form does not comply with these monographs. Moreover, according to the FDA, L-Choline Bitartrate is considered GRAS affirmed (21CFR182.8250_2010) but not the DL-form.” – http://www.geelawsonnutritional.com/news/gee-lawson-news/42-what-you-are-buying-might-not-be-the-right-source-of-choline.html

“Urolithiasis in rats consuming a dl bitartrate form of choline in a purified diet.” – https://www.ncbi.nlm.nih.gov/pubmed/16158911 — Urolithiasis = Kidney stone disease

Characteristics

DL-choline bitartrate

  • Smell: ?
  • Taste: ?

L-choline bitartrate

  • Smell: ?
  • Taste: ?
Return to "Choline bitartrate" page.